An update on quality control for the PFA-100/PFA-200

Platelet function testing is essential for evaluating hemostasis, especially in cases of bleeding or bruising. The PFA-100 system, now updated to the PFA-200, remains the primary tool for such assessments. Ensuring test accuracy requires internal and external quality control. However, these processes are complex for platelet function tests. Prior research has shown that quality assurance is challenging in this field. No prior work had resolved how to effectively apply quality control to the PFA systems. This uncertainty drove the need for updated approaches. The gap motivated a focus on reproducibility and consistency in test outcomes. This paper addresses that need through a decade-long analysis of quality control methods.

The study aimed to evaluate and refine internal and external quality control for the PFA-100 and PFA-200 systems. The specific problem is the logistical difficulty of maintaining test accuracy in platelet function assessments. The motivation comes from the need for reliable diagnostic tools in hemostasis. The authors sought to test new yet feasible approaches to quality assurance. Over ten years, they analyzed 43 challenges to assess system performance. The study focused on reproducibility and interpretive consistency. Recent data from the last four years were used to compare PFA-100 and PFA-200. The goal was to identify any variance between the two systems.

The study involved analyzing 43 challenges over ten years, with a focus on moderate to severe hemostasis defects. The last four years of data were used to compare PFA-100 and PFA-200 performance. Closure times (CTs) and interpretive comments were collected from participants. Statistical analysis included coefficients of variation (CVs) to assess reproducibility. Challenges were repeated to test consistency across runs. EQA results were compared against native whole blood benchmarks. Data were analyzed for deviations from expected values. The approach combined numerical and qualitative assessments to evaluate system behavior.

Closure times for each challenge fell within expected limits, showing good reproducibility. Repeated challenges demonstrated consistent results over time. Coefficients of variation ranged from 15% to 25%, matching or exceeding native whole blood data. Participant interpretations aligned with test data and expectations. No significant differences were found between PFA-100 and PFA-200 results. EQA material was also evaluated for internal quality control purposes. The data supported the reliability of both systems in platelet function testing. These findings suggest that current quality control methods are effective.

The study supports the use of internal and external quality control for the PFA-100 and PFA-200 systems. The authors propose that these processes are highly reproducible and reliable. They suggest that EQA and IQC can be used to monitor and improve test performance. No essential differences were found between the two systems in EQA results. The findings align with prior reports on platelet function testing accuracy. The authors emphasize that current methods are sufficient for quality assurance. Their claim is that these systems behave similarly in diagnostic settings. The implications suggest that these systems can be trusted for consistent hemostasis assessments.